Contract Manufacturing, Services
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
300
NCT06436911
To Evaluate Safety and Immunogenicity of a Prophylactic Plasmid DNA
Phase: Phase 1/2
Role: Collaborator
Start: Aug 31, 2024
Completion: Jul 31, 2026
Loading map...